Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Announces Record Preliminary Unaudited Fourth Quarter 2020 Revenue of EUR 15.3 Million [$18.3 million], an Increase of 28% Year-Over-Year
  Record HIFU revenue growth of 50% in the fourth quarter 2020 driven by the sale of eight HIFU devices sold during the quarter Achieved sequential quarterly revenue growth throughout 2020 notwithstanding challenges posed by the ongoing COVID-19 pandemic Company to announce fourth quarter and full
View HTML
Toggle Summary EDAP to Participate in B. Riley Securities Virtual Oncology Investor Conference
  LYON, France , January 19, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that Marc Oczachowski , President and CEO, will participate in a fireside chat at the B. Riley Securities Virtual Oncology Investor Conference on
View HTML
Toggle Summary EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored Clinical Study comparing HIFU to Radical Prostate Surgery
Results on 3,329 patients demonstrate significant difference in efficacy in favor of HIFU versus Radical Prostatectomy (RP) HIFU treatment also resulted in meaningful benefits in both urinary and erectile function versus RP showing superior quality of life preservation capability LYON, France ,
View HTML
Toggle Summary EDAP Issues Letter to Shareholders
  Recaps progress made in 2020 notwithstanding the ongoing COVID-19 pandemic and previews anticipated 2021 milestones LYON, France , January 6, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders:
View HTML
Toggle Summary EDAP to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event
  LYON, France , January 5, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that it will participate in the 10 th  Annual LifeSci Partners Corporate Access Event, January 6-8 and 11-14, 2021.
View HTML
Toggle Summary EDAP Announces End of the Year Focal One® Sales
Among December deals closed, two major US institutions have purchased Focal On   University of California, San Francisco Medical Center and Cleveland Clinic become latest to adopt Focal One high intensity focused ultrasound (HIFU) technology   Sales include a bundled sale with ExactVuTM as well as
View HTML
Toggle Summary EDAP Announces Final U.S. 2021 Reimbursement Rules for High Intensity Focused Ultrasound (HIFU)
   Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of malignant prostate tissue with HIFU in the US Physician reimbursement for HIFU approximately 30% higher than cryotherapy and brachytherapy Hospital reimbursement for HIFU up
View HTML
Toggle Summary EDAP Reports Third Quarter 2020 Results and Provides Operational Update
  Generated strongest total revenue quarter of 2020 Reported growth in HIFU procedure revenues year-over-year notwithstanding ongoing COVID-19 pandemic Completed sales to renowned healthcare institutions Mount Sinai Health System in New York and Keck Medical Center at the University of Southern
View HTML
Toggle Summary EDAP Announces Exclusive Distribution Agreement with Leading Italian Medical Device Distributor AB Medica
Partnership further extends the availability of EDAP’s High Intensity Focused Ultrasound (HIFU) technology to one of the largest markets in Europe Complementary to AB Medica’s extensive product portfolio which includes robotic surgery solutions as well as ExactVu LYON, France , November 17, 2020 --
View HTML
Toggle Summary EDAP Announces Presentation at the Jefferies Virtual London Healthcare Conference
LYON , France, November 10, 2020 --  EDAP TMS SA  (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the Jefferies Virtual London Healthcare Conference , which is being held November 17-19, 2020.  Presentation Details
View HTML